Search clinical trials for: epoetin alfa packed RBC transfusion

Total 659 results

Johnson & Johnson Pharmaceutical Research & Development...
Ortho Biotech Products, L.P.

Terminated

Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa

Anemia

United States
University of California, San Francisco
University of Washington; Thrasher Research Fund; UCSF Benioff Children's Hospital... and other collaborators

Completed

Neonatal Erythropoietin in Asphyxiated Term Newborns (NEAT)

Hypoxic-ischemic Encephalopathy

United States
Azidus Brasil

Unknown

PK and PD Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects

Healthy

Brazil
Medical University of Vienna

Completed

Erythropoietin and Platelet Activation Markers

Hypertension | Thrombosis

Austria
Queen's University
Ortho Biotech, Inc.

Terminated

REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial

Kidney Failure, Chronic | Drug Resistance

Canada
Max-Planck-Institute of Experimental Medicine
Johnson & Johnson; Parexel

Completed

Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke (ESS)

Infarction, Middle Cerebral Artery | Stroke, Acute | Middle Cerebral Artery Stroke

Germany
Alexion Pharmaceuticals

Completed

Acid Lipase Replacement Investigating Safety and Efficacy (ARISE) in Participants With Lysosomal Acid Lipase Deficiency (ARISE)

Lysosomal Acid Lipase Deficiency

France, Poland, United Kingdom, Spain, Mexico, Turkey, Japan, Australia, Russian Federation, United States, Germany, Italy, Czechia, Argentina, Croatia
University of Copenhagen

Completed

Tracing Changed Production of Red Blood Cells

Erythrocytosis | Erythropoiesis Abnormal

Denmark
Uniformed Services University of the Health Sciences
National Institutes of Health (NIH)

Withdrawn

Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Subacute TBI (TBI-EPO)

Traumatic Brain Injury

United States
Hoffmann-La Roche

Completed

A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.

Anemia

Serbia
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Anemia | Lung Cancer

United States
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions

Iron, Abnormal Blood Level

United States
University Hospital, Lille
University Hospital, Rouen; Centre Hospitalier Universitaire Dijon; University... and other collaborators

Recruiting

Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO (ICONE)

Anemia | Extracorporeal Membrane Oxygenation | Cardiogenic Shock | Transfusion Related Complication | Oxygen Delivery

France
Hoffmann-La Roche

Completed

A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis (ALTITUD)

Anemia, Kidney Disease, Chronic

Mexico
Hoffmann-La Roche

Completed

A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis

Anemia

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients

Anemia

Philippines
Hoffmann-La Roche

Completed

A Study of Monthly Subcutaneous Continuous Erythropoietin Receptor Activator (CERA) in Predialysis Participants With Chronic Renal Anemia (ORION)

Anemia

Italy
Azidus Brasil

Completed

PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant

Healthy

Brazil
Cairo University

Completed

Serum Erythropoietin Level in Perinatal Asphyxia

Perinatal Hypoxia

Egypt
Assiut University

Unknown

Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy

Hypoxic-Ischemic Encephalopathy
Sheri Kashmir Institute of Medical Sciences

Completed

Neuroprotective Role of Erythropoietin in Perinatal Asphyxia

Perinatal Asphyxia

India
Cardiochirurgia E.H.

Completed

Blood Sparing Strategies: Single Shot High Dose Erythropoietin Two Days Before Heart Surgery (SHOT)

Blood Transfusion

Italy
Rigshospitalet, Denmark
Danish Research Centre for Magnetic Resonance

Unknown

The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis (EPO-ProgMS)

Multiple Sclerosis (Primary or Secondary Progressive Phase).

Denmark
Chugai Pharmaceutical

Completed

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Chemotherapy Induced Anemia
Chugai Pharmaceutical

Completed

Clinical Study of R744 to Hemodialysis Patients

Hemodialysis Patients

Japan
Hoffmann-La Roche

Completed

A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.

Anemia

Russian Federation
Hoffmann-La Roche

Completed

A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.

Anemia

Germany
Yonsei University

Completed

EPO for Postop Delirium in Elderly Patients

Postoperative Delirium

Korea, Republic of
Rigshospitalet, Denmark

Unknown

Can Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?

Healthy

Denmark
Rabin Medical Center

Unknown

Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

Heart Failure

Israel
Zydus Lifesciences Limited

Completed

Desidustat in the Treatment of Anemia in CKD on Dialysis Patients (DREAM-D)

Chronic Kidney Disease Stage 5 on Dialysis

India
University of California, San Francisco
Washington University School of Medicine; Seattle Children's Hospital; Stanford... and other collaborators

Completed

Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO) (NEATO)

Neonatal Encephalopathy | Birth Asphyxia | Hypoxic-ischemic Encephalopathy

United States
Janssen-Cilag Ltd.,Thailand
Mahidol University

Terminated

An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy

Anemia - Cancer Related

Thailand
Cadila Pharnmaceuticals

Completed

Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure

Anemia

India
Seoul National University Bundang Hospital

Completed

The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction

Acute Myocardial Infarction

Korea, Republic of
Hoffmann-La Roche

Withdrawn

A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.

Anemia

Denmark
Hoffmann-La Roche

Terminated

Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia

Anemia

Sweden
Bruno Franco Mazza

Completed

Red Blood Cell Transfusion Improves Perfusion Parameters in Septic Shock Patients With Hypoperfusion

Septic Shock

Brazil
Hoffmann-La Roche

Completed

A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)

Renal Anemia of Chronic Kidney Disease

France
Hoffmann-La Roche

Completed

A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis.

Anemia

Netherlands
Hoffmann-La Roche

Completed

A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

Anemia

India
Hoffmann-La Roche

Terminated

A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal Anaemia

Anemia

Indonesia
Hoffmann-La Roche

Completed

LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

Anemia

Mexico, Colombia, Argentina, Venezuela, Brazil, Uruguay, Ecuador, Peru, Chile
Hoffmann-La Roche

Completed

A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis (MERCUR)

Anemia

Germany
Hoffmann-La Roche

Terminated

A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.

Anemia

Costa Rica, Guatemala, Argentina, Brazil, Panama, Chile, Colombia, Ecuador, Peru, Venezuela
Texas Tech University Health Sciences Center, El...

Completed

IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department

Iron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia Treatment | Iron Deficiency Anemia Due to Blood Loss

United States
Second Affiliated Hospital, School of Medicine,...
Zhejiang Cancer Hospital; First People's Hospital of Hangzhou; Ningbo Medical... and other collaborators

Recruiting

Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma

Lymphoma | Anemia

China
Second Xiangya Hospital of Central South University

Not yet recruiting

Evaluate the Efficacy and Safety of HIF-PHI for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis Patients

Anemia in Incident Dialysis Patients

China
Tehran University of Medical Sciences

Unknown

Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients (EPREX)

Multiple Trauma

Iran, Islamic Republic of
Hospices Civils de Lyon

Withdrawn

TETRAM 2. Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study (TETRAM2)

Spinal Trauma With Neurological Deficit

3

Subscribe